Latest It Services News

Vitrafy has added US blood network Versiti to its cryopreservation development programme, with the partnership focused on no-wash platelet preservation and regulatory verification. The deal strengthens the company’s institutional network, but initially generates no revenue and remains subject to US regulatory requirements.

Compumedics Limited (ASX:CMP) returned to profit in FY26 as record revenue, stronger cash generation and a sharp rise in MEG and SaaS sales reshaped its earnings profile. The company enters FY27 with A$28.3 million of open orders, but lower gross margins and uneven US and European execution remain key tests.

Vectus Biosystems has secured a pre-IND Type B meeting with the FDA for its lead IPF drug candidate VB0004. The regulator’s written feedback, expected by mid-November, should clarify the next US development steps but does not yet authorise clinical trials.

Alcidion will roll out its Miya Flow software across four Northern Care Alliance hospitals under a new A$7.5 million contract. About A$4.5 million is expected to be recognised as revenue in the current year, including a six-month renewal of the existing ExtraMed system during implementation.

Barton Gold has moved deeper into development after raising $40.9 million, completing its largest-ever drilling campaign and ending FY2026 with $31.9 million in cash. The progress came alongside a $22.4 million loss as spending accelerated across Tunkillia, Challenger, Tolmer and Wudinna.

Yugo Metals finished 2026 with A$6.29 million in cash after raising A$8.6 million, giving its Bosnia and Herzegovina exploration program more financial room. The trade-off was a net loss of A$3.93 million, more than double the previous year, alongside substantial equity issuance and ongoing funding risk.

Novatti has reported a statutory profit and positive EBITDA for FY26 after cutting low-margin revenue and concentrating on Payments AU/NZ. The turnaround is substantial, but an auditor-flagged going-concern uncertainty, upcoming debt maturities and negative operating cash flow leave the recovery unfinished.

Gratifii narrowed its FY26 net loss to $7.56 million, but continued cash burn, a $4.04 million net current liability deficit and an auditor warning leave its growth strategy dependent on fresh execution and funding. The ASX-listed loyalty technology company is also pursuing acquisitions and a $5 million Marketplacer investment whose benefits have yet to reach reported earnings.

EQ Resources has completed a sharp financial turnaround, moving from solvency concerns to a A$7.1 million FY2026 profit and A$28.2 million of cash. The recovery comes with lower annual production, serious safety shortcomings and substantial dilution, leaving execution as the test for its A$39 million Mt Carbine expansion.

Parkway Corporate Limited (ASX:PWN) delivered a sharp revenue increase in FY26 and generated positive operating cash flow, but slipped into a statutory loss and flagged significant uncertainty around its ability to continue as a going concern. Key approvals for its Queensland brine project and a new $2 million mining contract offer commercial progress, while funding remains the central test.

Identitii’s BNDRY platform gained customers and recurring revenue in FY26, but the company ended the year with just $107,483 in cash, negative net assets and a material uncertainty over its ability to continue as a going concern. A subsequent convertible note facility provides a committed $5 million, while access to a further $15 million remains conditional.

Castle Minerals has reported a $3.23 million net loss for FY2026, with its auditor highlighting material uncertainty over the explorer’s ability to continue without further capital or spending cuts. The company is redirecting its portfolio towards gold assets in Côte d’Ivoire and Western Australia, backed by a partly completed $4 million post-year-end placement.